Literature DB >> 17174023

Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.

Grégory Verhoest1, David Veillard, François Guillé, Alexandre De La Taille, Laurent Salomon, Clément Claude Abbou, Antoine Valéri, Eric Lechevallier, Jean-Luc Descotes, Herve Lang, Didier Jacqmin, Jacques Tostain, Luca Cindolo, Vincenzo Ficarra, Walter Artibani, Luigi Schips, Richard Zigeuner, Peter F Mulders, Arnaud Mejean, Jean-Jacques Patard.   

Abstract

OBJECTIVES: To analyse the influence of age at diagnosis on tumour characteristics and cancer-specific survival in renal cell carcinoma (RCC).
METHODS: Data on age, tumour characteristics, and survival for 4774 patients from 12 European RCC databases were recorded. Patients were divided into four groups according to age at diagnosis: < or =40, >40 and <60, > or =60 and <80, and > or =80 yr. The following variables were analysed: TNM stage, Fuhrman grade, tumour size, symptoms at diagnosis, ECOG performance status (PS), and cancer-specific survival. The groups were compared for usual clinical and pathologic variables, and cancer-specific survival.
RESULTS: The four groups accounted for 288 (6%), 1839 (38.5%), 2499 (52.3%), and 148 cases (3.2%), respectively. Differences were found among groups for tumour stage, symptoms at diagnosis, ECOG PS, Fuhrman grade (p<0.001), tumour size, M stage, and histologic subtype (p: 0.02). Patients < or =40 yr were more likely to have papillary or chromophobe RCCs and less likely to have clear-cell RCCs. No significant difference was found among groups for N stage (p: 0.15). The 5-yr cancer-specific survival rates for the four age categories were 85%, 74%, 70%, and 69%, respectively. In multivariate analysis age category remained an independent prognostic parameter (p<0.001).
CONCLUSIONS: Renal tumours diagnosed in younger age are characterized by lower tumour stages and grades as well as favourable histologic patterns compared with tumours in older patients. Basic research is required for explaining such a relationship between age, tumour aggressiveness, and therefore tumour biology.

Entities:  

Mesh:

Year:  2006        PMID: 17174023     DOI: 10.1016/j.eururo.2006.11.056

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  32 in total

1.  Determining the best treatment for renal cell carcinoma in young patients.

Authors:  Kenneth Pace
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

2.  Efficacy and safety of sunitinib in elderly patients with advanced renal cell carcinoma.

Authors:  Tetsuo Fujita; Takahiro Hirayama; Daisuke Ishii; Kazumasa Matsumoto; Kazunari Yoshida; Masatsugu Iwamura
Journal:  Mol Clin Oncol       Date:  2018-07-26

Review 3.  [Renal function in the elderly after radical tumor nephrectomy and partial nephrectomy].

Authors:  S Mehralivand; C Thomas; C Hampel; J W Thüroff; F C Roos
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

4.  Efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma.

Authors:  Hideaki Miyake; Ken-Ichi Harada; Seiichiro Ozono; Masato Fujisawa
Journal:  Med Oncol       Date:  2016-07-21       Impact factor: 3.064

5.  [Coping with small renal tumors in the elderly].

Authors:  A Häcker
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

6.  The prognostic significance of preexisting diabetes in patients with surgically treated renal cell carcinoma: the ongoing debate.

Authors:  Ho Won Kang; Yong-June Kim
Journal:  Ann Transl Med       Date:  2019-12

7.  The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma.

Authors:  Ho Won Kang; Sung Min Kim; Won Tae Kim; Seok Joong Yun; Sang-Cheol Lee; Wun-Jae Kim; Eu Chang Hwang; Seok Ho Kang; Sung-Hoo Hong; Jinsoo Chung; Tae Gyun Kwon; Hyeon Hoe Kim; Cheol Kwak; Seok-Soo Byun; Yong-June Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-12       Impact factor: 4.553

8.  Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.

Authors:  Ole-Petter R Hamnvik; Toni K Choueiri; Alexander Turchin; Rana R McKay; Lipika Goyal; Michael Davis; Marina D Kaymakcalan; Jonathan S Williams
Journal:  Cancer       Date:  2014-09-18       Impact factor: 6.860

9.  Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.

Authors:  Xiang Pan; Jing Quan; Liwen Zhao; Wenhua Li; Benlin Wei; Shangqi Yang; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-11-13

10.  Differential radiologic characteristics of renal tumours on multiphasic computed tomography.

Authors:  Boon Chye Ching; Hui Shan Tan; Puay Hoon Tan; Chee Keong Toh; Ravindran Kanesvaran; Quan Sing Ng; Min Han Tan
Journal:  Singapore Med J       Date:  2016-04-19       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.